MUCCI MARTIN

Director Martin Mucci purchases 1,200 shares of CTAS at $222.55; holdings increase 84.4% to 2,621 shares

Director Mucci purchased 1,200 shares of CINTAS at $222.55 on 2025-07-21, expanding his holdings by 84.4% from 1,421 to 2,621 shares for $267,060 total. The transaction occurred near the 52-week high of $227.66, only 2.8% below that level. Mucci's cross-ticker track record shows 5 prior sells with a 90-day well-timed rate of 25.00%, suggesting modest historical timing accuracy across other holdings. CINTAS trades at a P/E of 50.27 with recent revenue growth of +8.9% annually and $2.6B in latest quarterly revenue; the open-market purchase represents a discrete investment action by a director that increases his exposure to the company materially.

Director MUCCI MARTIN sold 97,526 PAYX shares for $14,157,849.42 at $145.17; now holds 446,917 shares (-17.9%)

MUCCI MARTIN, a director at Paychex, sold 97,526 shares at $145.17 on 2025-07-10, reducing his holdings by 17.9% from 544,443 to 446,917 shares and raising $14,157,849.42. Notably, at his prior four sales at PAYX (July 2024 and July 2023), the stock subsequently rose 4.2% to 15.1% over 90 days in three of four instances, with only one of those sales meeting the "well-timed" definition of negative 90-day returns; this pattern suggests his prior exits generally preceded gains rather than declines. The current stock price of $143.29 is 10.3% below the 52-week high and 1.3% below the transaction price, with the stock down 7.0% over 30 days and 2.4% over 90 days—a near-term decline that aligns with the well-timed outcome profile, though the historical pattern at this ticker does not strongly support a predictive signal of directional conviction.

PAYX Director Martin Mucci sold 187,348 shares for $21,926,714.36 across 3 sales July 1-2, 2024

Director Martin Mucci executed 3 separate sales totaling 187,348 shares for $21,926,714.36 at a blended average price of $117.04, reducing his holdings by 29.1% from 644,146 shares to 456,798 shares. The current stock price of $117.43 is 8.8% below the 52-week high of $128.79, and the stock has declined 2.3% over the past 30 days and 2.1% over 90 days. His prior PAYX sell on 2023-07-14 delivered a negative 90-day return of -1.6%, consistent with his cross-ticker track record of a 100.00% well-timed rate for sells (where negative post-sale returns indicate well-timed exits). This substantial divestiture by a director is material and warrants attention, though the absence of a 10b5-1 plan designation and the moderate post-trade price resilience prevent a higher significance rating.